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Abstract
Shiga toxins (Stx1 and Stx2) are a major pathogenic factor in enterohaemorrhagic
Escherichia coli O157: H7 infections that cause haemolytic-uremic syndrome, a serious
extraintestinal complication1. Shiga toxins consist of a a globotriaosylceramide (Gb(3))-
binding B subunit pentamer and an enzymic A subunit2. The ability for Shiga toxins to
bind to the surface of human neutrophils, a potential mediator for toxin translocation
and HUS pathogenesis, has been the object of controversy. It is demonstrated in
this study that Stx2 elicits a reproducible and consistent effect on isolated human
neutrophils which do not express Gb3, confirming previous work that Stx2 binds
in a non-classic mechanism to these cells. Stx2 induced a greater increase in the
expression of a specific inflammatory profile than Stx1 alone, particularly in TNF-alpha
expression (P<0.05, Student’s t-test). Moreover, co-stimulating neutrophils with LPS
appeared to nullify the Stx2 affect. In contrast, co-stimulating neutrophils with Stx1
and LPS appeared to increase the expression of IL-8 (P<0.05, Student’s t-test). This
observed activation of neutrophils and subsequent inflammatory profile provides a
better understanding of the role of host innate immunity in the pathogenesis of HUS.
References
1. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C. & Steele, B. T. (1983). Escherichia coli cytotoxin,
haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet 2, 1299-1300.
2. Fraser, M. E., Fujinaga, M., Cherney, M. M., Melton-Celsa, A. R., Twiddy, E. M., O’Brien, A. D. & James,
M. N. (2004). Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem 279,
27511-27517.
7
